Bayer is now going to conduct Phase 3 clinical trials for obstructive HCM in Japan, while Cytokinetics will expand its ongoing ACACIA-HCM and CEDAR-HCM trials into Japan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback